The Mumbai-based global pharma company, Wockhardt, on Thursday became the first Indian company to get the Drug Controller General of India (DCGI) approval for two of its novel antibiotics, Emrok (injectable) and Emrok O (oral). The new antibiotics will be launched in the next few months in domestic as well as Chinese markets. The antibiotics…